CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 2, 2004, Pages 116-121

  Vavassori, Piero ^a   Borgiani, Paola ^a   Biancone, Livia ^a   D'Apice, Maria Rosaria ^a   Del Vecchio Blanco, Giovanni ^a   Vallo, Laura ^a   De Nigris, Francesca ^a   Monteleone, Ivan ^a   Monteleone, Giovanni ^a   Pallone, Francesco ^a   Novelli, Guiseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CARD15; Crohn's disease; NOD2

Indexed keywords

ARGININE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOSINE; GLYCINE; LEUCINE; TRYPTOPHAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HYPOTHESIS; INTESTINE ENDOSCOPY; INTESTINE RADIOGRAPHY; INTESTINE STENOSIS; ITALY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INCIDENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; POLYMORPHISM, GENETIC; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 12144289474     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200403000-00009     Document Type: Article

References (26)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variant with susceptibily to Crohn's disease. Nature. 2001; 411:599-603.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
3. Hampe J, Cuthbert A, Croucher PJP, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001;157:1925-1928.
4. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:745-757.
5. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122: 854-866.
6. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002;122:867-874.
7. Vermiere S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet. 2002;71:74-83.
8. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002;359:1661-1665.
9. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002;123:679-688.
10. Radlmayr M, Torok HP, Martin K, et al. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology. 2002;122:2091-2092.
11. Murillo L, Crusius JB, van Bodegraven AA, et al. CARD15 gene and the classification of Crohn's disease. Immunogenetics. 2002;54:59-61.
12. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123:86-91.
13. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47:469-472.
14. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6-16.
15. Helio T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut. 2003;52:558-562.
16. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140-146.
17. Sugimura K, Taylor KD, Lin YC, et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet. 2003;72:509-518.
18. Lennard-Jones JE. Inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
19. Sambrooks J, Fritsch EF, Manitis T. Molecular cloning, laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1992.
20. Borgiani P, Vallo L, D'Apice MR, et al. Exclusion of CARD15 as a candidate susceptibility gene to psoriasis. Eur J Dermatol. 2002;12:540-542.
21. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science. 1998;281:363-365.
22. Bonen D, Nicolae D, Moran T, et al. Racial differences in Nod2 variation: characterisation of Nod2 in African-Americans with Crohn's disease (abstr). Gastroenterology. 2002;122:A29.
23. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812-4818.
24. Inohara N, Nuñez G. The NOD: a signaling module that regulates apoptosis and host defense against patogens. Oncogene. 2001;20:6473-6481.
25. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity. 2001;15:5-14.
26. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003;124:993-1000.